von Rueden D G, Sessions S C
Division of General Surgery, Lankenau Hospital, Wynnewood, Pennsylvania 19096.
Am Surg. 1994 Jan;60(1):72-8.
Breast cancer treatment has undergone significant changes in concept, concurrent with alterations in our understanding of cancer biology and natural history. Within the last 10 years, oncologists have brought into question the traditional Halstedian concepts of the natural history of breast cancer and its appropriate management. The goal of treatment, once a primary cancer is detected in the breast, is to prevent metastasis and subsequent death of the patient. One hundred forty-two female patients over the age of 65 with histologically confirmed breast cancer were treated at Lankenau Hospital from 1982 to 1990. We treated 32 women over the age of 65 with quadrantectomy and tamoxifen as the sole form of therapy. No radiation, standard chemotherapy, nor axillary dissection was utilized. A cohort of 110 women of similar age, treated for breast cancer with "standard therapy" (total mastectomy or "segmental resection" and radiation with axillary nodal dissection) during the same time period, were also analyzed retrospectively. All segmental resections were followed by standard radiation doses to the ipsilateral breast and draining nodal basins with a local boost. Twenty-nine of 32 patients in the quad + tam group were available for follow-up 1 to 8 years following treatment (mean 52 months). The cumulative overall survival was 67 per cent and disease-free survival 92 per cent. No patient developed local recurrence. Follow-up analysis of the 110 women treated in "standard fashion" was complete in 88 patients 1 to 8 years post-treatment (mean 56 months). Cumulative overall survival was 82 per cent and disease-free survival 83 per cent. Local recurrence was noted in five per cent.(ABSTRACT TRUNCATED AT 250 WORDS)
乳腺癌治疗在概念上经历了重大变革,这与我们对癌症生物学和自然史的理解变化同步。在过去10年里,肿瘤学家对乳腺癌自然史及其恰当治疗的传统霍尔斯特德概念提出了质疑。一旦在乳房中检测到原发性癌症,治疗目标就是预防转移及患者随后的死亡。1982年至1990年期间,兰肯瑙医院对142名65岁以上经组织学确诊为乳腺癌的女性患者进行了治疗。我们对32名65岁以上的女性采用象限切除术和他莫昔芬作为唯一治疗方式。未进行放疗、标准化疗或腋窝淋巴结清扫。同时,对一组年龄相仿的110名在同一时期接受“标准治疗”(全乳切除术或“节段性切除”及腋窝淋巴结清扫放疗)的乳腺癌女性患者进行了回顾性分析。所有节段性切除术后均对同侧乳房和引流淋巴结区域给予标准放疗剂量并局部加量。象限切除加他莫昔芬组的32名患者中有29名在治疗后1至8年(平均52个月)可进行随访。累积总生存率为67%,无病生存率为92%。无患者发生局部复发。对88名接受“标准方式”治疗的110名女性患者在治疗后1至8年(平均56个月)进行了随访分析。累积总生存率为82%,无病生存率为83%。局部复发率为5%。(摘要截选至250词)